Drug preparation comprising α-lipoic acid, ambroxol and/or inhibitors of the angiotensin-converting enzyme (ACE) and its use for the treatment of neurodegenerative diseases

US7858655B2 · kind B2 · utility

Assignee

• Keyneurotek Pharmaceuticals AG · DE

Inventors

• Peter Rohnert · Magdeburg, DE
• Frank Striggow · Gerwisch, DE
• Klaus Reymann · Magdeburg, DE
• Siegfried Ansorge · Hohenwarthe, DE
• Michael Täger · Heinrichsberg, DE
• Ulrich Schröder · Bischofswerda, DE

Key dates

• Filing date: Jan 26, 2004
• Grant date: Dec 28, 2010
• Expiry date: Jan 26, 2024

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention concerns the use of Provided is a drug composition and a method for using the composition for the prevention and the therapy of neurodegenerative diseases. The combination comprises at least two of the following substances: α-lipoic acid; ambroxol and one or several inhibitor(s) of the angiotension-converting enzyme (ACE).